- Hepatitis B Surface Antigen Test (HBsAg)
- Anti-hepatitis B Surface Antibody Test
- Hepatitis B Core Antigen Test (HBcAb)
- Anti-hepatitis B Core Antibody Test
- HBV DNA Test
Hepatitis B Virus Testing Market size is valued at USD 849.07 million in 2021 and is expected to reach USD 1319.44 million by 2028, at a CAGR of 6.5% during the forecast period 2022-2028. Increase in liver cancer cases, growing aging population, healthcare spending and urbanization. leading to better monitoring and screening procedures. In addition, government initiatives in growing awareness in public, increase in R&D spending by companies and growing demand for bio marker tests due to its accuracy expected to boost the hepatitis B virus testing market during the forecast period. However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition and high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period. Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). Hepatitis B viral infection ranges can form mild infection which last few weeks and a chronic infection that may lead to liver disorders and even death. Hepatitis B is one of the global health problem. Hepatitis B can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. The virus is transmitted through contact with the blood or other body fluids of an infected person. According to World Health Organization, 257 Mn people are living with hepatitis B virus infection worldwide and in 2015, 887 000 hepatitis B resulted deaths. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Hepatitis B Virus Testing Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed globalÂ Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Fastest Growing Market
The rise in global hepatitis B prevalence might be attributed to the growth of the hepatitis B diagnostic testing market. According to the World Health Organization, it affects more than 300 million people worldwide. Furthermore, it is well-known that its frequency is particularly high in the Western Pacific and African regions. Perinatal transmission and horizontal transfer by infected blood are both prominent causes of infection in endemic areas. Increased public awareness, as well as increased government and non-profit initiatives, all contribute to the market's growth. As people become more aware of the disease, it gets diagnosed earlier. Hepatitis B diagnostic tests are in high demand as a result of this. The global hepatitis B diagnostic testing market is expected to be hampered by a lack of common recommendations for hepatitis B diagnosis.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.